Prostate cancer is the second main reason behind cancer loss of life in males within the U.S., with an anticipated 288,000 circumstances and 34,700 deaths anticipated in 2023, per the American Cancer Society.
As synthetic intelligence-based well being applied sciences proceed to advance, a rising variety of medical tech companies need to use AI to enhance affected person outcomes. One of those is ArteraAI, a agency in Jacksonville, Florida, that develops medical AI exams that assist personalize therapy for cancer sufferers.
Among the company’s options is the ArteraAI Prostate Test, described as the primary of its sort for sufferers with localized prostate cancer.
COULD A URINE TEST DETECT PANCREATIC AND PROSTATE CANCER? STUDY SHOWS 99% SUCCESS RATE
For every affected person, the test seems to be at two items of knowledge: a biopsy of the cancerous tumor and sure scientific information, defined Dr. Andre Esteva, a California-based medical AI researcher who’s the CEO of ArteraAI.
“From that, it will predict the likely outcomes for the patient and help the physician to determine the optimal therapy,” he informed Fox News Digital in an interview. (SEE the video just under for extra of Dr. Esteva’s on-camera feedback.)
The course of is easy, he mentioned. The clinician orders a test from ArteraAI’s web site, then ships a biopsy pattern to the company’s lab.
After the AI evaluation, ArteraAI sends again a report.
“We are the first-ever predictive test in localized prostate cancer that can help a clinician identify the best treatment for a patient,” Esteva mentioned.
MOST MEN DIAGNOSED WITH PROSTATE CANCER DON’T NEED TO RUSH TO SURGERY, RADIATION TREATMENTS: STUDY
The test focuses on each prognostic and predictive parts. The prognostic facet helps the doctor decide the long-term outcomes of the affected person, Esteva defined. The predictive half is what helps to personalize the person therapy for the affected person.
The ArteraAI Prostate Test gives the benefit of quick turnaround instances, its CEO informed Fox News Digital.
“Let’s say that you’re a clinician and your patient has been diagnosed, and you’re considering whether or not you should intensify their therapy,” he mentioned.
“And you’re wondering, ‘Is this therapy intensification actually going to benefit my patient or is it simply going to lead to additional toxicities?’ Our tests can help you determine that.”
The ArteraAI Prostate Test additionally gives the benefit of quick turnaround instances, he added.
“From the time the sample is received, it is a one- or two-day turnaround for the clinician to get a test report back,” Esteva mentioned. “Most conventional technologies take weeks to process.”
Test in motion: Ohio oncologist sees advantages
Dr. Dan Spratt, chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical Center, started utilizing ArteraAI’s Prostate Test final yr.
After his sufferers are identified — sometimes by scans, biopsies and/or PSA (prostate-specific antigen) ranges — he sends samples with the test to find out which therapies can be simplest primarily based on the affected person’s information and the aggressiveness of the cancer.
ArteraAI, a Florida-based agency, has developed the ArteraAI Prostate Test, known as the primary predictive test for sufferers with localized prostate cancer. (iStock)
“The ArteraAI test takes the tissue from a man’s biopsy and digitizes it, then runs a highly sophisticated algorithm using artificial intelligence to tell you how best to personalize therapy,” Spratt defined to Fox News Digital in an interview.
There are different exams accessible that take the tissue and extract some genetic materials from it, however ArteraAI’s test makes use of a “non-destructive method,” so the tissue remains to be intact and can be utilized for different issues, the physician mentioned.
COULD A URINE TEST DETECT PANCREATIC AND PROSTATE CANCER? STUDY SHOWS 99% SUCCESS RATE
“One of the things we struggle with in prostate cancer, when a man is sitting in front of me, is how do I know if he’s a patient that I don’t even need to treat or a patient who might die of this disease?” Spratt mentioned.
“Artificial intelligence is going to revolutionize health care for the better.”
“And so that’s a big struggle, to have these conversations with patients with the tools we use today, which are moderately accurate.”
He mentioned that “having a tool that’s highly accurate really makes it easier to recommend treatment … there’s this extra confidence now.”
AI exams intention to enrich well being care suppliers, not exchange them
ArteraAI’s CEO mentioned he believes that “artificial intelligence is going to revolutionize health care for the better.”
Said Esteva, “I think it will help make health care far more ubiquitous — and really enhance our providers and be scalable in a way that conventional techniques haven’t been.”
Prostate cancer is often identified through imaging scans, PSA (prostate-specific antigen) exams and biopsies. One CEO mentioned he doesn’t anticipate the brand new know-how to exchange medical suppliers’ jobs. (iStock)
He doesn’t anticipate the know-how to exchange medical suppliers’ jobs.
“What ArteraAI does in no way affects anyone’s livelihood or job,” he mentioned. “Our test fits into the clinician’s workflow, so after a patient has been diagnosed by a pathologist and a physician, when an oncologist or urologist is trying to determine how to best treat that patient, our tests will help them make that decision.”
He added, “We are strictly complementary to their work.”
Medical AI reveals promise as caveats stay
Dr. Jennifer Bepple, a Maryland-based board-certified urologist and adviser to Verana Health, a digital well being company in San Francisco, mentioned she believes that AI gives an amazing alternative in well being care.
“It allows us to gain insights into the large amount of data generated in health care by supporting real-world evidence,” she informed Fox News Digital.
Advancements in AI might additionally assist pathologists in decoding biopsies, mentioned one urologist.
“To assist with advancements in point of care for our patients, specifically those with prostate cancer, AI could be utilized to analyze images for indications of malignancy,” she informed Fox News Digital.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Advancements in AI might additionally assist pathologists in decoding biopsies, Bepple added.
“Furthermore, AI can help advance efforts in precision medicine, tailoring screening and management for cancer patients, by analyzing a wide range of variables from demographics and clinical factors to social determinants of health,” she mentioned.
“Our test fits into the clinician’s workflow, so after a patient has been diagnosed by a pathologist and a physician, when an oncologist or urologist is trying to determine how to best treat that patient, our tests will help them make that decision,” Dr. Esteva mentioned. (iStock)
There is, nonetheless, the necessity to defend sufferers’ privateness and safety by conserving information sources nameless, Bepple famous.
Another potential concern is the presence of bias in any of the algorithms used within the AI fashions.
“In order to have reliable algorithms, we must ensure that the data represents the entire population that it’s intended to treat,” she mentioned.
It’s additionally essential {that a} clinician confirms the accuracy of any output from AI fashions, Bepple mentioned.
CLICK HERE TO GET THE FOX NEWS APP
Added the physician, “AI will serve as a useful clinical tool — but its true role will be to support the most sacred part of health care: the patient-physician relationship.”
